Genetic analysis and identification of new tumor suppressor genes in childhood acute Lymphoblastic leukemia

儿童急性淋巴细胞白血病的遗传分析及新抑癌基因的鉴定

基本信息

  • 批准号:
    18591071
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

1. Long-Term Study of the Clinical Significance of Loss of Heterozygosity in Childhood Acute Lymphoblastic Leukemia Acute lymphoblastic leukemia (ALL) is one of the most common malignancies in childhood, with a widely variable outcome. Differences in the behavior and prognosis of the leukemia suggest that ALL can be divided into several biologic subgroups. We analyzed the loss of heterozygosity (LOH) of 6q, 9p, 11q, and 12p using 31 microsatellite sites to determine their overall frequency and clinical value. We have studied 244 primary ALL samples obtained from the Multicenter Trial ALL-BFM 90 of Childhood ALL group. These patients have now been followed clinically for over 8 years. LOH occured in 169 (69%) individuals in the following frequencies: 6q, 49 patients (20%); 9p, 97 patients (40%); 11q, 29 patients (12%); 12p, 60 patients (25%). Clinical data showed that those with 6q LOH were younger (p=0.01) and had lower WBC counts (P=0.02); patients with 9p LOH more frequently had CNS … More involvement (p=0.01) and T cell phenotype (p=0.0001); individuals with 11q LOH had a good response to induction chemotherapy (p=0.02); those with 12p LOH were younger(1)=0.005), frequently had precursor B ALL (p=0.001), and had a longer event-free survival (p=0.05). Taken together, these data confirm that LOH is a very frequent alteration in childhood ALL.2. Aberrant Methylation in Promoter-associated CpG Islands of Multiple Genes in Acute Lymphoblastic Leukemia Methylation profile was analyzed in ten childhood acute lymphoblastic leukemia (ALL) and nine adult ALL cases. Four genes (p15, p16, RAR〓, FHIT) had methylation in both diseases, four genes (p14, Rb, MLH1, DAPK) showed no methylation in both diseases, and the two genes (APC, RIZ) demonstrated methylation only in adult ALL. Methylation of the RAR〓 was more frequent in adult ALL than childhood ALL (v0.01). The number of patients with methylation of multiple genes was higher in adult ALL than childhood ALL (p=0.006). Moreover, overall frequency of methylation was higher in adult ALL than childhood ALL (p=0.01). Less
1。关于儿童期杂合性丧失的临床意义的长期研究,急性淋巴细胞性白血病急性淋巴细胞白血病(ALL)是儿童期最常见的恶性肿瘤之一,有广泛可变的结果。白血病的行为和预后的差异表明,所有这些都可以分为几个生物学亚组。我们使用31个微卫星位点分析了6q,9p,11q和12p的杂合性(LOH)的损失,以确定其总频率和临床值。我们研究了244个主要样本,这些样本从童年的多中心试验全BFM 90分组中获得。这些患者现已在临床上进行了8年以上。 LOH在以下频率下发生在169名(69%)的人中:6q,49例患者(20%); 9p,97例患者(40%); 11q,29例患者(12%); 12p,60例患者(25%)。临床数据表明,患有6Q LOH的人年轻(p = 0.01),WBC计数较低(p = 0.02); 9p LOH的患者频繁患有CNS…更多的参与(P = 0.01)和T细胞表型(P = 0.0001); 11q LOH的个体对诱导化疗有很好的反应(p = 0.02);那些具有12p LOH的人年轻(1)= 0.005),经常具有前体B全部(P = 0.001),并且无事件生存期较长(P = 0.05)。综上所述,这些数据证实LOH是童年时期经常发生的。2。急性淋巴细胞白血病甲基化甲基化的启动子相关甲基化的异常甲基化在十个儿童期急性淋巴细胞性白血病(全部)和9例成年病例中分析了急性淋巴细胞白血病甲基化甲基化甲基化。四个基因(p15,p16,rar〓,fHIT)在两种疾病中均甲基化,四个基因(p14,rb,mlh1,dapk)在两种疾病中均未显示甲基化,而两种基因(APC,RIZ)仅在成人中仅显示出甲基化。在成年人中,RAR的甲基化比童年时代更频繁(v0.01)。成年人的甲基化患者数量高于童年的所有基因的数量(p = 0.006)。此外,成年人的总体甲基化频率高于所有童年(p = 0.01)。较少的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Loss of H19 imprinting in adult T-cell leukaemia/lymphoma
  • DOI:
    10.1111/j.1365-2141.2007.06581.x
  • 发表时间:
    2007-05-01
  • 期刊:
  • 影响因子:
    6.5
  • 作者:
    Takeuchi, Seisho;Hofmann, Wolf-Karsten;Koeffler, H. Phillip
  • 通讯作者:
    Koeffler, H. Phillip
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEUCHI Seisho其他文献

TAKEUCHI Seisho的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEUCHI Seisho', 18)}}的其他基金

Development of therapy and identification of new tumor suppressor genes in childhood acute Lymphoblastic leukemia
儿童急性淋巴细胞白血病治疗方法的开发和新抑癌基因的鉴定
  • 批准号:
    20591132
  • 财政年份:
    2008
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

基于外泌体通讯探讨LOH发病的睾酮合成微环境机制及雄蚕益肾方干预研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
基于乏氧-ROS-Leydig细胞自噬途径的补肾活血法治疗LOH作用机制研究
  • 批准号:
    82074446
  • 批准年份:
    2020
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
LncRNA LOH12CR2 通过调控RNA甲基化在丁酸钠抑制结直肠癌中的作用机制研究
  • 批准号:
    81972288
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
TP53 LOH及RB1基因在EGFR突变肺腺癌脑膜转移的发生机制研究
  • 批准号:
    81802298
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
NGF激活HPG轴促性腺激素合成的分子机制及其对LOH的治疗作用研究
  • 批准号:
    81871150
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Carcinogenic pathway and prognosis of gastric cancer in young patients : genome instability and DNA methylation
年轻患者胃癌的致癌途径和预后:基因组不稳定性和DNA甲基化
  • 批准号:
    21790363
  • 财政年份:
    2009
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of early diagnostic methods for metastasis and a new metastasis-related gene in head and neck cancer
开发头颈癌转移的早期诊断方法和新的转移相关基因
  • 批准号:
    19791229
  • 财政年份:
    2007
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Genetic and epigenetic analyses of folate and nudeotide metabolizing enzymes in gastrointestinal cancer
胃肠癌叶酸和核苷酸代谢酶的遗传和表观遗传分析
  • 批准号:
    18591458
  • 财政年份:
    2006
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SIAH1の肝発癌における関与の解明と肝癌遺伝子治療の可能性に関する研究
阐明SIAH1与肝癌发生的关系及肝癌基因治疗的可能性研究
  • 批准号:
    16659355
  • 财政年份:
    2004
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Exploratory Research
Molecular Pathological analyses of aberrant expression of the proteintyrosine phosphatase SHP1 gene in terms of lymphomagenesis/leukemogenesis.
蛋白酪氨酸磷酸酶 SHP1 基因在淋巴瘤发生/白血病发生方面的异常表达的分子病理学分析。
  • 批准号:
    15590302
  • 财政年份:
    2003
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了